Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

WEHI scientists discovered a drug that blocks long COVID in mice and may improve acute treatment options beyond current ...

Combining pioneering iPSC technology and patented live cell bioimaging, LumiSTAR is opening up exciting new possibilities in the treatment of various diseases and the development of innovative new dru ...

Uncertainty surrounding US tariffs and global economic headwinds has tempered hiring in India's pharma and healthcare GCCs.

ProFuse's novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of ...

Ottawa, April 14, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global drug discovery market size was evaluated at USD 65.88 billion in 2024 and is predicted to grow around USD 160.31 ...

As the Trump administration continues federal funding cuts, the effects are trickling down to mid-Michigan. Jamie Bernard, ...

For one, microglia hovering around plaques—the type that express the most TREM2—reportedly become desensitized to stimulation ...

PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced ...

Elix Inc. has entered into a drug discovery collaboration with Prism Biolab Co. Ltd. to accelerate AI-driven drug discovery for challenging protein-protein interaction targets. The partnership will ...

AMPLY, the company behind the proprietary AMPLYfolioAI platform, is accelerating the discovery of new medicines for complex ...